Glenmark Pharma receives USFDA nod for Norethindrone Acetate & Ethinyl Estradiol Capsules

Glenmark Pharma receives USFDA nod for Norethindrone Acetate & Ethinyl Estradiol Capsules

by admin- Friday, July 29th, 2022 03:30:23 PM

Glenmark Pharmaceuticals Inc., USA (Glenmark) has acquired final approval by using the US Food & Drug Administration (USFDA) for Norethindrone Acetate and Ethinyl Estradiol Capsules and Ferrous Fumarate Capsules, 1 mg/20 mcg, the conventional version of Taytulla Capsules, of Allergan Pharmaceuticals International Ltd.

News Updates